Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Microbiology and Immunology
Explore this Website
Home
About Us
Toggle About Us menu options
Open Positions
Programs of Study
Contact Us
Additional Resources
Our Faculty
Seminar Series
Toggle Seminar Series menu options
Carl Nathan, M.D. Lectureship
Toggle Carl Nathan, M.D. Lectureship menu options
2025-2026 Academic Year Program
Work In Progress Seminars
Publications
News and Events
Toggle News and Events menu options
Events
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Our Faculty
Seminar Series
Publications
News and Events
Home
Publications
You are here
Home
>
Publications
>
Publications
Publications
Found 718 results
Author
Title
Type
[
Year
]
Filters:
First Letter Of Last Name
is
M
[Clear All Filters]
2024
Arias AA, Neehus A-L, Ogishi M, Meynier V, Krebs A, Lazarov T, Lee AM, Arango-Franco CA, Yang R, Orrego J et al.
. 2024.
Tuberculosis in otherwise healthy adults with inherited TNF deficiency.
.
Nature. 633(8029):417-425.
Song M, Huang S, Wu X, Zhao Z, Liu X, Wu C, Wang M, Gao J, Ke Z, Ma X et al.
. 2024.
UBR5 mediates colorectal cancer chemoresistance by attenuating ferroptosis via Lys 11 ubiquitin-dependent stabilization of Smad3-SLC7A11 signaling.
.
Redox Biol. 76:103349.
Hahn WO, K Parks R, Shen M, Ozorowski G, Janes H, Ballweber-Fleming L, Davis ASWoodward, Duplessis C, Tomai M, Dey AK et al.
. 2024.
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.
.
J Exp Med. 221(10)
Hahn WO, K Parks R, Shen M, Ozorowski G, Janes H, Ballweber-Fleming L, Davis ASWoodward, Duplessis C, Tomai M, Dey AK et al.
. 2024.
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.
.
J Exp Med. 221(10)
Hahn WO, K Parks R, Shen M, Ozorowski G, Janes H, Ballweber-Fleming L, Davis ASWoodward, Duplessis C, Tomai M, Dey AK et al.
. 2024.
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.
.
J Exp Med. 221(10)
Hahn WO, K Parks R, Shen M, Ozorowski G, Janes H, Ballweber-Fleming L, Davis ASWoodward, Duplessis C, Tomai M, Dey AK et al.
. 2024.
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.
.
J Exp Med. 221(10)
Hahn WO, K Parks R, Shen M, Ozorowski G, Janes H, Ballweber-Fleming L, Davis ASWoodward, Duplessis C, Tomai M, Dey AK et al.
. 2024.
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.
.
J Exp Med. 221(10)
2023
Zi Z, Du S, Zhang L, Wang Y, Ding L, Zhang C, Wang H, Pawlicki J, Cai Y, Yao Y et al.
. 2023.
Aberrant expression of GOLM1 protects ALK+ anaplastic large cell lymphoma from apoptosis by enhancing BCL-XL stability.
.
Blood Adv. 7(15):4049-4063.
Garg A, Sanchez AM, Miele M, Schwer B, Shuman S
. 2023.
Cellular responses to long-term phosphate starvation of fission yeast: Maf1 determines fate choice between quiescence and death associated with aberrant tRNA biogenesis.
.
Nucleic Acids Res. 51(7):3094-3115.
Colin P, Ringe RP, Yasmeen A, Ozorowski G, Ketas TJ, Lee W-H, Ward AB, Moore JP, Klasse PJ
. 2023.
Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
.
Retrovirology. 20(1):9.
de Miranda R, Cuthbert BJ, Klevorn T, Chao A, Mendoza J, Arbing M, Sieminski PJ, Papavinasasundaram K, Abdul-Hafiz S, Chan S et al.
. 2023.
Differentiating the roles of Mycobacterium tuberculosis substrate binding proteins, FecB and FecB2, in iron uptake.
.
PLoS Pathog. 19(9):e1011650.
Morillo RCampelo, Harris CT, Kennedy K, Henning SR, Kafsack BFc
. 2023.
Genome-wide profiling of histone modifications in Plasmodium falciparum using CUT&RUN.
.
Life Sci Alliance. 6(1)
Caniels TG, Medina-Ramírez M, Zhang J, Sarkar A, Kumar S, LaBranche A, Derking R, Allen JD, Snitselaar JL, Capella-Pujol J et al.
. 2023.
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions.
.
Cell Rep Med. 4(4):101003.
Caniels TG, Medina-Ramírez M, Zhang J, Sarkar A, Kumar S, LaBranche A, Derking R, Allen JD, Snitselaar JL, Capella-Pujol J et al.
. 2023.
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions.
.
Cell Rep Med. 4(4):101003.
Caniels TG, Medina-Ramírez M, Zhang J, Sarkar A, Kumar S, LaBranche A, Derking R, Allen JD, Snitselaar JL, Capella-Pujol J et al.
. 2023.
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions.
.
Cell Rep Med. 4(4):101003.
Ringe RP, Colin P, Ozorowski G, Allen JD, Yasmeen A, Seabright GE, Lee JHyun, Antanasijevic A, Rantalainen K, Ketas T et al.
. 2023.
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
.
PLoS Pathog. 19(10):e1011601.
Capucci S, Wee EG, Schiffner T, LaBranche CC, Borthwick N, Cupo A, Dodd J, Dean H, Sattentau Q, Montefiori D et al.
. 2023.
HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
.
PLoS One. 18(10):e0293148.
Capucci S, Wee EG, Schiffner T, LaBranche CC, Borthwick N, Cupo A, Dodd J, Dean H, Sattentau Q, Montefiori D et al.
. 2023.
HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
.
PLoS One. 18(10):e0293148.
Sharma I, Fang J, Lewallen EA, Deitsch KW, McCutchan TF
. 2023.
Identification of a long noncoding RNA required for temperature induced expression of stage-specific rRNA in malaria parasites.
.
Gene. 877:147516.
Prabhu M, Yang YJ, Johnston CD, Murphy EA, Ketas TJ, Díaz-Tapia R, Jurkiewicz M, Racine-Brzostek S, Mohammed I, Sukhu AC et al.
. 2023.
Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons.
.
Am J Obstet Gynecol MFM. 5(2):100796.
Prabhu M, Yang YJ, Johnston CD, Murphy EA, Ketas TJ, Díaz-Tapia R, Jurkiewicz M, Racine-Brzostek S, Mohammed I, Sukhu AC et al.
. 2023.
Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons.
.
Am J Obstet Gynecol MFM. 5(2):100796.
Prabhu M, Yang YJ, Johnston CD, Murphy EA, Ketas TJ, Díaz-Tapia R, Jurkiewicz M, Racine-Brzostek S, Mohammed I, Sukhu AC et al.
. 2023.
Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons.
.
Am J Obstet Gynecol MFM. 5(2):100796.
Prabhu M, Yang YJ, Johnston CD, Murphy EA, Ketas TJ, Díaz-Tapia R, Jurkiewicz M, Racine-Brzostek S, Mohammed I, Sukhu AC et al.
. 2023.
Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons.
.
Am J Obstet Gynecol MFM. 5(2):100796.
Coloma J, Gonzalez-Rodriguez N, Balaguer FA, Gmurczyk K, Aicart-Ramos C, Nuero ÓM, Luque-Ortega JRomán, Calugaru K, Lue NF, Moreno-Herrero F et al.
. 2023.
Molecular architecture and oligomerization of Candida glabrata Cdc13 underpin its telomeric DNA-binding and unfolding activity.
.
Nucleic Acids Res. 51(2):668-686.
Ottavi S, Li K, Cacioppo JG, Perkowski AJ, Ramesh R, Gold BS, Ling Y, Roberts J, Singh A, Zhang D et al.
. 2023.
Mycobacterium tuberculosis PptT Inhibitors Based on Heterocyclic Replacements of Amidinoureas.
.
ACS Med Chem Lett. 14(7):970-976.
« first
‹ previous
1
2
3
4
5
(current)
6
7
8
9
…
next ›
last »